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Abstract: 
 
The aim of this study was to determine if 3-wks of short-term, high-intensity exercise training 
(HIT) alters growth hormone (GH) release. Nineteen recreationally active males (Mean ± SD) 
(age = 24.9 ± 3.9 yrs, BF% = 20.1 ± 7.7) participated in this study. Each subject completed a 2-
hr resting profile and a 2-hr acute sprint (AS) profile that consisted of one maximal 30-sec 
Wingate sprint on a cycle ergometer after 30 min of rest. Blood samples were taken every 15 min 
[Q15] during rest and more frequently [Q1-Q10] immediately following the sprint. Short-term, 
HIT consisted of 4-6 repetitions of 30-sec maximal sprints relative to body mass, 3 times·wk-1 
with an additional AS profile at the end of each week of training for 3 wks. Peak power (PP) and 
fatigue index (FI) significantly increased while mean power (MP), minimum power (MinP), time 
to peak power (TTPP), and total work per sprint (TW) were unchanged after 3 wks of HIT. Total 
body mass significantly increased and was confirmed by a significant increase in lean mass of 
the lower extremities. Growth hormone area under the curve (AUC) and peak GH were 
significantly decreased after the first week of HIT despite no change in time to reach peak GH. 
One week of HIT significantly decreased GH release, with a simultaneous significant increase in 
anaerobic power and lean body mass of the lower extremities. 
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Article: 
 
INTRODUCTION 
 
Human growth hormone (GH) is one of the seven-peptide hormones produced and secreted from 
the anterior lobe of the pituitary gland (22). In the plasma, most GH is bound to GH-binding 
proteins and is taken up by specific GH receptors on target cells and thus, has effects on local 
tissue such as increased lipid metabolism via increased free fatty acid (FFA) mobilization and 
decreased triglyceride formation (13,23). Additionally, GH has been linked to the increase in 
lean muscle mass and strength (8).   
 
Alterations in exercise intensity and duration (equating to increases in workload) have been 
shown to increase the GH response in a positive linear fashion (24-27). Furthermore, shorter 
bouts of high-intensity exercise elicit an elevated growth hormone response. Peak GH secretion 
occurs ~30 to 40 min after the beginning of a sprint exercise and one acute bout of maximal 
exercise as short as 6 sec (19) can stimulate a significant GH pulse that typically returns to 
baseline within 90 to 120 min (18-21).   
 
While the effects of acute exercise on GH release are well documented, there is less agreement in 
the literature about the effect of training on the resting and exercise-induced GH response. This 
outcome is likely due in part to the various populations and training protocols utilized. Although 
one training study in elite swimmers has reported an augmented GH response to 18 wks of 
training (1), most controlled training studies have reported that training attenuates the exercise-
induced GH response (3,5,17,28). Previous research (17) has shown that peak GH concentration 
was decreased by 40% after 6 wks of short-term, high-intensity sprint training and similar reports 
have indicated that the GH response is attenuated after only 3 wks of training (28).    
 
The primary purpose of this study was to examine the time course and magnitude of the GH 
adaptation, anthropometric and anaerobic performance changes to 3 wks of high-intensity sprint 
exercise training on a cycle ergometer using a weekly measure of hormonal responses and 
exercise performance. We hypothesized that the exercise-induced GH response to an acute sprint 
(Wingate test) would be blunted with sprint training, but the physiological adaptation would 
occur much sooner than previoiusly reported. Secondarily, sprint interval training has been 
shown to reduce fat mass and increase fat-free mass in as little as 6 wks of training consisting of 
3 days·wk-1 of 4 to 6 30-sec maximal sprints (7). Furthermore, it has been reported that 6 
sessions of sprint-training with 1 to 2 rest days between each session significantly increased 
muscle oxidative potential, increased cycling endurance capacity, and elevated peak power 
output (2). Similar to the GH adaptation, we believe these anthropometric and anaerobic 
performance changes may occur earlier than 6 wks with high-intensity sprint training but would 
have no association with the exercise-induced GH response.   
 
METHODS  
 
Subjects 
Nineteen recreationally active male subjects (24.9 ± 3.9 yrs) participated in this study. The 
subjects were screened prior to participation for contraindications to exercise and factors known 
to affect GH secretion, including hematological, renal, hepatic, metabolic, and thyroid function. 
Subjects were excluded if they: (a) had a BMI less than 18 or greater than 30 kg·m-2; (b) reported 
a history of hematological, renal, hepatic, metabolic, or thyroid dysfunction; (c) were currently 
on a caloric restriction program; (d) participated in more than 10 hrs of recreational activities 
(swimming, basketball, jogging, cycling, etc.) per week; and/or (e) were involved in any type of 
sprint training 6 months prior to the study. All subjects were provided a written informed consent 
in accordance with the institutional review board at the University of North Carolina at 
Greensboro and Winston-Salem State University. 
 
 
Procedures 
Experimental Design 
Subjects completed three separate laboratory visits prior to starting the training program. During 
the first visit, total and regional body composition were measured by a trained technician using a 
whole body dual energy X-ray absorptiometry scan (DXA) (Lunar-Prodigy Advance Plus). 
Then, each subject completed an exercise protocol familiarization test on an electronically-
braked cycle ergometer (Lode Excalibur Sport, Lode BV, Gronignen, The Netherlands). After 48 
to 72 hrs, the subjects reported back to the laboratory between 7:00 a.m. and 9:00 a.m. after an 
overnight fast (8 to 12 hrs) to complete a baseline resting 2-hr blood profile.  
 
Resting and Acute Sprint Exercise-Induced GH Profiles 
Prior to each GH profile, the subjects were asked to refrain from exercising for the previous 24 
hrs. An intravenous catheter was inserted into the forearm by a trained technician. Patency was 
maintained by displacing the blood in the catheter with isotonic saline. Blood samples were 
taken on average every 15 min [Q15] for 2 hrs with more frequent sampling near the time that 
exercise would occur during the exercise trials (0, 15, 30 [sprint], 31 [immediate post-exercise], 
35, 45, 60, 75, 90, 105, and 120 min). Blood samples were collected in vacutainers (10 mL) and 
a total of 110 mL of blood was collected over the 2-hr time frame.  
 
The subjects returned to the laboratory 1 wk later to complete their first 2-hr sprint protocol. The 
same protocol as the resting GH profile was followed, except the subjects rested for 20 min after 
catheter insertion prior to beginning a standardized warm-up on the cycle ergometer. The warm-
up consisted of pedaling against 60 W of resistance for 4 min, 80 W for 30 sec, and 100 W for an 
additional 30 sec. Then, the subjects rested for 5 min while the 30-min pre-exercise blood draw 
was performed. Immediately following the draw, the subjects were instructed to begin pedaling 
at maximal pedal speed for 2 to 3 sec at which point a resistance load equivalent to 7.5% of each 
subject’s body weight was applied for one maximal 30-sec sprint. Each subject was verbally 
encouraged to give his maximal effort during the maximal sprint. Immediately after the exercise 
test, a post-exercise blood sample was taken while the subject remained seated on the ergometer. 
Immediately afterwards, each subject moved into a chair to rest comfortably for the remaining 
blood draws.  
 
Short-Term, High-Intensity Exercise Training (HIT) 
The training protocol used in this study was based on similar high-intensity protocols published 
by Burgomaster et al. (2) and Gibala et al. (4). Training began 24 hrs after the completion of the 
acute exercise testing session. It consisted of 4 to 6 repetitions of 30-sec maximal sprints, 3 
times·wk-1 for 3 wks. One day of rest intervened each training session. The first 3 training 
sessions consisted of four 30-sec repetitions at 7.5% body mass with 4 min of active recovery at 
50 W between each repetition. Training sessions 4 to 6 (wk 2) consisted of 5 repetitions, and 
sessions 7 to 9 (wk 3) consisted of six 30-sec maximal repetitions. During each repetition, each 
subject was encouraged verbally to provide maximal effort. At the end of each week, 48 hrs after 
the third training session for the week, subjects completed the acute sprint test protocol outlined 
previously (including blood draws). At least 48 hrs after the final blood profile, a post-training 
DXA scan was completed as outlined previously.   
 
 
Blood Sampling and Analysis 
Blood samples were allowed to clot at room temperature for 30 min. Samples were then 
centrifuged at 3000 rev·min-1 for 15 min at 4ºC. Serum was extracted and pipetted into 
microcentrifuge tubes and stored at -80ºC until subsequently analyzed. Growth hormone 
concentration at all time points was determined in duplicate using a human GH enzyme-linked 
immunosorbant assay (MP Biomedicals, Solon, OH). The minimum detectable dose of this assay 
was 0.5 µg·L-1. The intra-assay variance was 2.2 to 2.9%. To eliminate inter-assay variance, all 
samples from a single subject were assayed within the same plate.   
 
Statistical Analyses 
Paired samples t-tests were used to evaluate changes in body composition pre-training versus 
post-training. A repeated measures ANOVA with Greenhouse-Geisser correction was used to 
assess whether there were differences in anaerobic performance during the acute sprints at the 
end of each week of training compared to pre-training. When the data were non-normally 
distributed, a Wilcoxon signed-rank test was used to adjust for skewedness. Friedman 
nonparametric tests for several related samples with Wilcoxon post-hoc follow ups and 
appropriate Bonferroni corrections were conducted to assess if there were differences among the 
mean ranks of the mean GH area under the curve (AUC), peak GH, time to peak GH and total 
GH concentrations during each sprint x time point in order to determine how the individual GH 
profiles fluctuated on a weekly basis as a result of HIT. Mean GH AUC was calculated using the 
trapezoidal integration method. The AUC was calculated as previously described by Stokes et al. 
(20). The level of statistical significance was set at P≤0.05.  All statistical analyses were 
performed using PASW for Windows, version 22.0 (Chicago, Illinois, USA). All results are 
expressed as means ± SEM, unless otherwise noted.  
 
RESULTS 
 
Table 1. Pre-Training vs. Post-Training Changes in Body Composition. 
Variable Pre-Training Post-Training P Adjusted P‡ 
BMI (kg·m-2) 26.1 ± 2.6 26.2 ± 2.6 0.402  
Total Body Mass (kg)   86.9 ± 13.4   87.9 ± 13.4   0.007†  
Arms Mass (kg) 10.6 ± 1.7 10.4 ± 1.7 0.071  
Legs Mass (kg) 29.9 ± 4.7 30.7 ± 5.0   0.000†  
Total Body Fat % 20.1 ± 7.7 19.9 ± 8.4 0.406  
Arms Body Fat % 12.7 ± 5.7 12.6 ± 6.2 0.586 0.542 
Legs Body Fat % 19.9 ± 7.4 19.5 ± 7.7 0.089  
Total Lean Body Mass (kg) 65.8 ± 8.3 66.7 ± 8.4  0.020*  
Arms Lean Mass (kg)   8.8 ± 1.6   8.6 ± 1.5 0.134  
Legs Lean Mass (kg) 22.5 ± 2.9 23.3 ± 3.2   0.000†  
Total Body Fat (kg) 17.4 ± 8.6 17.4 ± 9.3 0.957 0.904 
Arms Fat (kg)   1.3 ± 0.7   1.3 ± 0.7 0.112  
Legs Fat (kg)   5.7 ± 3.0   5.9 ± 3.0 0.176 0.212 
*P<0.05; †P<0.01. ‡When the data were non-normally distributed, P values were adjusted for skewedness (>1.0) 
using the nonparametric Wilcoxon sign-ranked test. Values are mean ± SD. 
 
 
Body Composition 
Body mass index and total percent body fat were unchanged despite an increase in total body 
mass pre-training versus post-training (Table 1). Results indicate that the increase in total body 
mass was a result of the increase in total lean body mass with no change in total body fat 
accumulation. Regional body composition analysis revealed that total leg mass was increased 
and that this change was the result of an increase in the total lean mass of the legs without a 
change in total fat content of the legs. Upper body mass content distribution remained unchanged 
pre-training versus post-training. 
 
Figure 1. (a) Peak Power; (b) Peak Power-Corrected for Subjects’ Body Mass; and (c) 
Fatigue Index during Each 30-sec Maximal Cycle Ergometer Acute Sprint (AS) Before and 
After 3 wks of HIT; and (d) Total Combined Workload of Every Sprint during Each 
Training Week. Values are mean ± SD. *Greater than AS1 (P<0.01). †Greater than AS1-AS3 
(P<0.05).  ‡Greater than training weeks 1 and 2 (P<0.01). §Greater than training week 1 
(P<0.01).  
 
Exercise Performance 
The training protocol used in this study increased workload for three successive weeks by 
increasing the total number of sprints per training day by one per week. As expected, results 
indicated that the total work per training week increased each week (P = 0.000) (Figure 1d).   
 
Peak power (PP) and peak power corrected to the subjects’ body mass (PP-corr) increased after 
HIT (P = 0.002 and P = 0.013, respectively). Post-hoc t-test comparisons for paired samples 
revealed that PP and PP-corr increased after just the 1st wk of training (P = 0.002 and P = 0.002, 
respectively) with no additional improvements in PP or PP-corr following the additional 2 wks of 
training (Figure 1a/b). However, PP and PP-corr increased 12% and 20% respectively, over 3 wks 
of HIT. Mean power (MP) (P = 0.280) and mean power corrected to the subjects’ body mass (MP-
corr) (P = 0.282), as well as the time to reach peak power (TTPP) (P = 0.741), and minimum power 
throughout the 30-sec sprint tests (MinP) (P = 0.359) were all unchanged with training (Table 2).  
Fatigue index (FI) increased 28% after training (P = 0.003) and post-hoc t-test comparisons 
revealed that FI increased after each week of training (Figure 1c). However, despite the increase 
in PP and PP-corr, the total work (TW) during the single acute 30-sec sprint at the end of each 
week was unchanged during HIT (P = 0.280) (Table 2).  
 
Table 2. Anaerobic Performance.   
Variable Sprint 1 Sprint 2 Sprint 3 Sprint 4 
MP (W)   657 ± 190 664 ± 170 649 ± 129 609 ± 141 
MP-corr (W)   7.5 ± 1.4 7.7 ± 1.4 7.6 ± 1.2 6.9 ± 1.9 
PP (W) 1237 ± 163 1329 ± 241* 1359 ± 302* 1389 ± 283* 
PP–corr (W) 14.3 ± 1.2 15.4 ± 1.8* 15.7 ± 2.6* 16.2 ± 5.3* 
MinP (W)   394 ± 203 350 ± 120  360 ± 112  323 ± 129 
TTPP (sec)   1.4 ± 0.9 1.7 ± 1.2  1.7 ± 1.1  2.4 ± 3.6 
FI (%) 30 ± 7  35 ± 10*   36 ± 12*    38 ± 13† 
TW (W) 19704 ± 5695     19926 ± 5086 19462 ± 3863 18272 ± 4215 
Mean power (MP), mean power corrected for each subject’s body mass (MP-corr), peak power (PP), peak power 
corrected for each subject’s body mass (PP-corr), minimum power (MinP), time to reach peak power (TTPP), 
fatigue index (FI) and total work per sprint (TW) during each acute sprint (AS) throughout the 3-wk training period. 
*Greater than AS1 (P<0.01). †Greater than AS1-AS3 (P<0.05). Values are mean ± SD. 
 
Growth Hormone 
Exercise elicited a GH response immediately following one acute 30-sec sprint on a cycle 
ergometer, regardless of HIT (P = 0.000) (Figure 2). However, the exercise-induced GH 
response was attenuated after only 1 wk of HIT (P = 0.048) (Table 3). More specifically, GH 
AUC was greater during sprint 1 (AS1) compared to the acute sprints (AS2 – AS4) after each 
week of HIT (P = 0.002 [AS2], P = 0.002 [AS3], and P = 0.014 [AS4]). Even though total 
workload was similar between all sprints before and after the end of each training week (Table 
2), the exercise-induced GH response divided by total work output (KJ) was still attenuated with 
training overall (P = 0.045) and was greater during AS1 compared to AS2 – AS4 (P = 0.001 
[AS2], P = 0.003 [AS3], and P = 0.010 [AS4]). Peak exercise-induced GH also decreased overall 
(P = 0.036) and was greater during AS1 compared to after the first and second weeks of HIT 
(AS2 – AS3) (P = 0.002 [AS2], P = 0.003 [AS3]) but similar to AS4 after the final week of HIT 
(P = 0.064). Regardless of the attenuated GH AUC, HIT had no effect on the time to reach peak 
exercise-induced GH release after each week of HIT (P = 0.180).    
 
 
Figure 2. Exercise-Induced Growth Hormone (µg·L-1) during a 2-hr Profile that Included 
one 30-sec Sprint at Min-30.  Profiles were collected before (AS1) and during three consecutive weeks of 
sprint training at the end of each week (AS2 – AS4).  *Exercise produced a significant GH response regardless of 
training (main effect of exercise, P<0.01). †GH AUC was significantly greater during AS1 compared to all other 
acute sprint GH profiles (main effect of group, P<0.01). ‡GH concentration was significantly elevated at timepoints 
45 to 120 during AS1 compared to AS2-4 (exercise-training interaction effect, P<0.01).  
 
Table 3. Exercise-Induced Growth Hormone Before and After 3 wks of HIT. 
Variable Sprint 1 Sprint 2 Sprint 3 Sprint 4 
GH AUC (μg·L-1·min-1) * ‡   505.2 ± 112.2 232.4 ± 66.3 224.2 ± 67.4   286.7 ± 112.8 
GH AUC/KJ (μg·L-1·min-1·W) * † 27.1 ± 6.1 11.8 ± 3.1 10.7 ± 2.9 14.3 ± 4.8 
Peak GH (μg·L-1) * §   8.9 ± 2.0   4.0 ± 1.1   3.6 ± 1.0   5.2 ± 1.7 
Time to Peak GH (min) 30.0 ± 3.8 20.6 ± 5.0  27.1 ± 6.2 16.5 ± 3.6 
*Friedman nonparametric tests for several related samples indicated a difference across all four sprints (P<0.05). 
†Post hoc Wilcoxon signed-rank tests indicated that the GH AUC sprint profile 1 was greater than GH AUC sprint 
profiles 2, 3, and 4 (P<0.01).  ‡Post hoc Wilcoxon signed-rank tests indicated that the GH AUC sprint profile 1 was 
greater than GH sprint profiles 2, 3 (P<0.01), and 4 (P<0.05). §Post hoc Wilcoxon signed-rank tests indicated that 
the GH sprint profile 1 was greater than GH sprint profiles 2 and 3 (P < 0.01), but not 4 (P = 0.064). Values are 
mean ± SEM.  
 
Growth hormone concentration was elevated 120-min post-exercise compared to rest following 
the AS1 (P = 0.014), 105-min after the 1st wk of HIT (AS2, P = 0.020), 90-min after the 2nd wk 
of HIT (AS3, P = 0.036), and 105-min after the 3rd wk of HIT (AS4, P = 0.014). However, HIT 
also altered the exercise-induced GH recovery profile. Fifteen minutes after the onset of exercise 
(timepoint 45) during AS1 prior to HIT, the GH concentration was elevated compared to all 3 
subsequent acute sprints (AS2 – AS4) following 3 wks of HIT (P = 0.002) and remained elevated 
for the remainder of the 120-min profile.   
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DISCUSSION 
 
The major findings of this study indicate that exercise-induced GH release in response to short-
term, high-intensity exercise training is attenuated in as little as 1 wk of training. This attenuation 
in GH release occurred: (a) even after sequentially increasing workload each week of training; 
and (b) in concert with the increase in lean mass of the lower extremities and greater peak power 
anaerobic performance.  
 
Our findings are in agreement with several other studies that have reported an attenuated GH 
response to exercise training (3,5,10,17,28). Because the literature seldom states the time lapse 
between the last training session and the testing sessions, it is often difficult to dissociate chronic 
from acute effects of exercise on the outcome variables. This is particularly true of GH, since 
repetitive bouts of exercise with short recovery periods and inadequate rest between training 
days have been shown to attenuate GH release (3,5,17,18,28). Based on prior observations (9,18) 
there is an optimal recovery period (>120 min) between exercise sessions for maximal exercise-
induced GH release. In the current study, a single 30-sec acute exercise sprint occurred at the end 
of each week 48 hrs after the previous training day. Therefore, we suggest that the attenuated GH 
response observed in the current study was the result of chronic exercise training and that any 
effect of acute exercise was negligible.  
 
The attenuated GH response seen with high-intensity exercise training may be linked to 
increased tissue sensitivity to GH. Due to the chronic and repetitive presence of GH that 
continually feeds back to the pituitary and hypothalamus during training, the magnitude of the 
GH response may fluctuate in response to a given exercise stimulus (i.e., a greater exercise 
intensity to elicit a greater GH response). Another possible mechanism causing the attenuated 
GH response might be the enhanced negative feedback of IGF-1 on GH release (15). 
Additionally, increased affinity of GH binding proteins (GHBP) and GH receptor desensitization 
further displays the complexity of the hypothalamic-pituitary axis. The level of plasma GHBP is 
inversely related to the GH concentration and the percentage of GH bound to GHBP can vary 
from 10% to 80% over a 24-hr period (22).  
 
In a chronic fluctuating hormonal environment, such as repetitive high-intensity training that 
coincides with troughs of GH release, it is possible that a shift in GH binding kinetics may be 
related to changes in GH production, clearance, and secretory patterns. For example, the mass of 
GH secreted during exercise after 6 weeks of training decreased 37% of distribution volume and 
the half-life of GH disappearance decreased 23% (28). Additionally, GH parameters such as 
maximal GH peak height, incremental GH peak amplitude, GH peak area, nadir GH 
concentration, and 24-hr integrated serum GH have been reported to increase in women who 
trained above the lactate threshold for 1 yr (25). This signifies the dose response relationship that 
training may have on GH secretion parameters. This is also important considering that pulsatile 
secretion determines more than 85% of the daily GH AUC release and that the pulsatile release 
of GH is more effective at producing a biological response than continuous release in certain 
tissues like bone, muscle, and liver where GH plays a metabolic role (22).  
 
Studies (4,17) using short-term sprint or interval training at higher intensities have reported small 
improvements in anaerobic performance. Most high-intensity training studies (25,28) that 
reported an increase in exercise performance trained for at least 6 wks, which is similar to Stokes 
et al. (17) who reported a 6% increase in peak power after 6 wks of training. Interestingly, our 
subjects had a 12% increase in peak power after only 3 wks of high-intensity training. 
Improvements in anaerobic performance in a short period of time (typically <3 wks) are most 
likely the result of enhanced neuromuscular activity (6) that could also explain our increase in 
peak power. However, Stokes et al. (17) reported that post-exercise plasma ammonia 
concentrations, reflecting reduced muscle ammonia, decreased with 6 wks of sprint-training. 
They suggested that this may have improved the balance between ATP hydrolysis and 
resynthesis during training leading to the small improvements they recorded in mean power.  
 
Additionally, Rodas and colleagues (14) reported significant increases in phosphocreatine (31%) 
and glycogen (32%) as well as other markers of muscle oxidative capacity from vastus lateralis 
tissue after only 2 wks of sprint-training. It is possible that subjects in our study had 
improvements in muscular enzymatic activity, such as improvements in adenylate kinase activity 
and reduced muscle ammonia, but the time course for these physiological adaptations may take 
longer than 3 wks to occur. Thus, this might be the reason that we did not see any changes in 
mean power in our shorter training time frame.  
 
Similar high intensity resistance training programs that focused on lower extremity hypertrophy 
have reported change in as little as 4 wks (16). Lamont et al. (12) reported an increase in total 
lean body mass (2.1%) and lower leg lean mass (2.5%) after 6 wks of high-intensity resistance 
squat training.  In the current study, 3 wks of HIT significantly increased overall total body mass 
1.2% and total lean body mass (1.2%) with no change in overall fat mass. The increase in total 
body mass and lean mass coincided with a significant increase in total mass (1.4%) and total lean 
mass of the lower extremities (3.6%). Therefore, HIT resulted in a significant change in overall 
mass as a direct result of increased lean mass of the lower extremities that was likely related to 
the cycling training program.  
 
It has been reported that growth hormone is needed for the acquisition of lean muscle mass and 
strength (8). However, our results demonstrate that lean mass can increase in the presence of an 
attenuated GH response during high-intensity training. This may be linked to previous 
observations suggesting a change in GH secretory dynamics and binding kinetics leading to 
altered bioavailability (25,28). Additionally, no studies have examined the effect of a high-
intensity training program on the subsequent 24-hr GH concentrations or the fact that training 
can alter GH molecular heterogeneity leading to the secretion of GH molecular mass variants 
that have higher bioactivity (11). These exercise training-induced factors might all influence 
physiological adaptations that lead to changes in body composition.   
 
Practical Applications 
Exercise program design focusing on maximal effort over short time frames (2 to 3 min·d-1 x 3 
d·wk-1) can lead to significant improvements in anaerobic performance and lean body mass after 
only 3 wks of short term-high intensity training. This is a suitable alternative to time consuming, 
low-intensity exercise for subjects who are capable of exercising at maximal capacity. 
Furthermore, the changes in peak power output and lower extremity lean body mass suggest that 
the training program is suitable training for individuals who are engaged in sporting events that 
require lower body power output.  
 
CONCLUSIONS 
 
The results of this study indicate that short-term, high-intensity sprint training results in 
decrements in the exercise-induced GH response after only 1 wk of HIT. This physiological 
adaption to training occurred in a much shorter time frame than the previous research had 
documented. Also, the findings suggest that training at higher absolute intensities and continually 
increasing workloads does not off-set the initial decrement in exercise-induced GH release that is 
observed when HIT is initiated. Improvements in anaerobic performance and lean body mass can 
occur despite an attenuated GH response during short-term, high-intensity training. More studies 
need to identify the time course of high-intensity training on GH binding kinetics and secretory 
parameters. Perhaps, the attenuated GH response to training does not necessarily suggest that 
less GH is available for biological action in certain tissues, but that the metabolic action of GH is 
altered as a result of training-induced changes in GH bioavailability and not total GH release. 
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